Little Green PharmaASX:LGP Market Cap is A$52.48 Mil as of Jun. 27, 2026. The stock has 3 warning signs investors should review. Among 1,023 Drug Manufacturers companies, Little Green Pharma ranks worse than 71.95% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Little Green Pharma's share price for the quarter that ended in Mar. 2026 was A$0.097. Little Green Pharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 305.86 Mil. Therefore, Little Green Pharma's market cap for the quarter that ended in Mar. 2026 was A$29.67 Mil.
Little Green Pharma's quarterly market cap
increased
from Mar. 2025 (A$37.92 Mil) to Sep. 2025 (A$40.50 Mil) but then
declined
from Sep. 2025 (A$40.50 Mil) to Mar. 2026 (A$29.67 Mil).
Little Green Pharma's annual market cap
declined
from Mar. 2024 (A$42.01 Mil) to Mar. 2025 (A$37.92 Mil) and
declined
from Mar. 2025 (A$37.92 Mil) to Mar. 2026 (A$29.67 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Little Green Pharma's Enterprise Value for Today is A$55.75 Mil.
Little Green Pharma (ASX:LGP) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Little Green Pharma Market Cap Related Terms
Little Green Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for Little Green Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Little Green Pharma Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Little Green Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Little Green Pharma's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma (ASX:LGP) has a Market Cap of A$52.48 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Little Green Pharma and its competitors. According to the industry distribution chart, Little Green Pharma ranks #736 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 71.9%.
Is Little Green Pharma's Market Cap too high?
Little Green Pharma's current Market Cap is A$52.48 Mil. Based on the distribution chart, Little Green Pharma ranks #736 out of 1023 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Little Green Pharma's Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Little Green Pharma ranks #736 out of 1023 companies for Market Cap. This places Little Green Pharma in the lower half of its industry. The industry median Market Cap is 205.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Little Green Pharma and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Little Green Pharma's current Market Cap is A$52.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.06 — trading 62.4% below its estimated fair value. The current Market Cap is A$52.48 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current Market Cap is A$52.48 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:LGP has been successfully added to your 